Interestingly, in the model of pressure overload-induced cardiac remodeling, Adam et al. [52] demonstrated that DNMT3B inhibition 5-AZA ameliorates cardiac fibrosis, establishing DNMT3B as a potential therapeutic target for HF. Here, DNMT3B is linked to hydrops fetalis.